دورية أكاديمية
Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese Adults
| العنوان: | Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese Adults |
|---|---|
| المؤلفون: | Li, ChenAff1, Aff2, Liu, Haiyan, Liao, Yixiang, Zhu, Yu, Tian, Jingyuan, Wang, Xuan, Hu, Zhiqin, Zhan, Yaoxuan, Li, Xianbo, Liang, Xintong, He, Jin, Li, Yongmei, Shang, Dewei, Zheng, Qingshan, Wang, TenghuaAff1, IDs40259023006047_cor15, Song, HaifengAff5, IDs40259023006047_cor16, Fang, YiAff6, IDs40259023006047_cor17 |
| المصدر: | BioDrugs. 37(5):721-735 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 11738804 1179190X |
|---|---|
| DOI: | 10.1007/s40259-023-00604-7 |